(ALZN) Alzamend Neuro - Performance -92.3% in 12m
ALZN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-86.67%
#160 in Peer-Group
Rel. Strength
0.77%
#7617 in Stock-Universe
Total Return 12m
-92.33%
#198 in Peer-Group
Total Return 5y
-99.98%
#198 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 52.65 USD |
| 52 Week Low | 2.88 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 77.31 |
| Buy/Sell Signal +-5 | -0.64 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ALZN (-92.3%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ALZN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALZN
| Total Return (including Dividends) | ALZN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.13% | 3.64% | 4.08% |
| 3 Months | -55.99% | 23.43% | 19.65% |
| 12 Months | -92.33% | -7.41% | 12.88% |
| 5 Years | -99.98% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | ALZN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -53.8% | 30.3% | 86.9% |
| 3 Months | -94.4% | 79.4% | 97.2% |
| 12 Months | -98.7% | -87.3% | 46% |
| 5 Years | -98.6% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th28.00 | -11.36% | -11.73% |
| 3 Month | %th1.00 | -64.34% | -63.22% |
| 12 Month | %th1.50 | -91.72% | -93.21% |
| 5 Years | %th0.50 | -99.97% | -99.99% |
FAQs
Does Alzamend Neuro (ALZN) outperform the market?
No,
over the last 12 months ALZN made -92.33%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months ALZN made -55.99%, while XBI made 23.43%.
Performance Comparison ALZN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ALZN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.7% | -12.2% | -78.5% | -105% |
| US NASDAQ 100 | QQQ | 3.9% | -12.2% | -79.8% | -103% |
| German DAX 40 | DAX | 1.6% | -10% | -90.5% | -124% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.2% | -13.4% | -82.8% | -113% |
| Hongkong Hang Seng | HSI | 4.9% | -10.6% | -98.7% | -129% |
| India NIFTY 50 | INDA | 4.7% | -8.2% | -77.9% | -90% |
| Brasil Bovespa | EWZ | 9.2% | -10% | -94.5% | -95% |
ALZN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5% | -10.3% | -82% | -115% |
| Consumer Discretionary | XLY | 3.7% | -10.6% | -70.8% | -109% |
| Consumer Staples | XLP | 5% | -8% | -77.6% | -100% |
| Energy | XLE | 1.8% | -13.3% | -72% | -95% |
| Financial | XLF | 4.6% | -11.7% | -82.2% | -120% |
| Health Care | XLV | 3.1% | -9.1% | -68.5% | -87% |
| Industrial | XLI | 2.9% | -13% | -85.5% | -118% |
| Materials | XLB | 2.8% | -12.4% | -81.9% | -99% |
| Real Estate | XLRE | 4.2% | -7.6% | -77.9% | -104% |
| Technology | XLK | 3.7% | -15% | -82.7% | -101% |
| Utilities | XLU | 2.9% | -11% | -80.8% | -115% |
| Aerospace & Defense | XAR | 3.4% | -14.7% | -96.6% | -141% |
| Biotech | XBI | 0.1% | -11.8% | -68.8% | -85% |
| Homebuilder | XHB | 0.4% | -16.5% | -74.1% | -98% |
| Retail | XRT | 3.4% | -10.9% | -72.9% | -103% |
ALZN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.5% | -13.4% | -63.5% | -86% |
| Natural Gas | UNG | 7% | 0% | -50.1% | -87% |
| Gold | GLD | 4.1% | -8% | -93.4% | -132% |
| Silver | SLV | 3% | -9.7% | -92.3% | -112% |
| Copper | CPER | -5.3% | -21.5% | -99.4% | -115% |
ALZN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.7% | -9.8% | -74% | -90% |
| iShares High Yield Corp. Bond | HYG | 4% | -9.4% | -75% | -102% |